APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oncolytic Virus

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

Selected research

Market Structure

Global Oncolytic Virus Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025172 pages

Choose your research edition.

Industry ResearchOncolytic Virus Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Oncolytic Virus Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Oncolytic Virus Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oncolytic Virus Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Oncolytic Virus Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

To date, two genetically engineered oncolytic viruses have been approved for marketing as drugs. One is Oncorine (H101, the same construct as ONYX‐015),9 an E1B‐deleted adenovirus, which was approved in China for head and neck cancer and esophagus cancer in 2005. The use and clinical data of Oncorine is so far limited to China. The other is T‐Vec (talimogene laherparepvec, IMLYGIC, formerly OncoVEXGM‐CSF), which was approved for melanoma by the FDA in the USA in October 2015 and was subsequently approved in Europe in January 2016 and in Australia in May 2016. For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. Market competition is intense. Amgen, Shanghai Sunway Biotech, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. Other players include Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics and Cold Genesys, etc.

This report provides an overview of the global Oncolytic Virus market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Oncolytic Virus and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oncolytic Virus sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oncolytic Virus market size, projected growth trends, production technologies, key applications, and end-use industries.

Oncolytic Virus Segment by Company

Amgen

Shanghai Sunway Biotech

Oncolytic Virus Segment by Type

Imlygic

Oncorine

Others

Oncolytic Virus Segment by Application

Melanoma

Other Cancers

Oncolytic Virus Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncolytic Virus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oncolytic Virus and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncolytic Virus.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oncolytic Virus market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oncolytic Virus manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oncolytic Virus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oncolytic Virus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oncolytic Virus Industry Trends Table 2. Oncolytic Virus Industry Drivers Table 3. Oncolytic Virus Industry Opportunities and Challenges Table 4. Oncolytic Virus Industry Restraints Table 5. Global Oncolytic Virus Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oncolytic Virus Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oncolytic Virus Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Oncolytic Virus Sales Market Share by Manufacturers Table 9. Global Oncolytic Virus Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Oncolytic Virus Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oncolytic Virus Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oncolytic Virus Manufacturers, Product Type & Application Table 13. Global Oncolytic Virus Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oncolytic Virus by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Imlygic Table 17. Major Manufacturers of Oncorine Table 18. Major Manufacturers of Others Table 19. Global Oncolytic Virus Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Oncolytic Virus Sales by Type (2021-2026) & (K Units) Table 21. Global Oncolytic Virus Sales by Type (2027-2032) & (K Units) Table 22. Global Oncolytic Virus Sales Market Share by Type (2021-2026) Table 23. Global Oncolytic Virus Sales Market Share by Type (2027-2032) Table 24. Global Oncolytic Virus Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Oncolytic Virus Revenue by Type (2021-2026) & (K Units) Table 26. Global Oncolytic Virus Revenue by Type (2027-2032) & (K Units) Table 27. Global Oncolytic Virus Revenue Market Share by Type (2021-2026) Table 28. Global Oncolytic Virus Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Melanoma Table 30. Major Manufacturers of Other Cancers Table 31. Global Oncolytic Virus Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Oncolytic Virus Sales by Application (2021-2026) & (K Units) Table 33. Global Oncolytic Virus Sales by Application (2027-2032) & (K Units) Table 34. Global Oncolytic Virus Sales Market Share by Application (2021-2026) Table 35. Global Oncolytic Virus Sales Market Share by Application (2027-2032) Table 36. Global Oncolytic Virus Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Oncolytic Virus Revenue by Application (2021-2026) & (K Units) Table 38. Global Oncolytic Virus Revenue by Application (2027-2032) & (K Units) Table 39. Global Oncolytic Virus Revenue Market Share by Application (2021-2026) Table 40. Global Oncolytic Virus Revenue Market Share by Application (2027-2032) Table 41. Global Oncolytic Virus Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Oncolytic Virus Sales by Region (2021-2026) & (K Units) Table 43. Global Oncolytic Virus Sales Market Share by Region (2021-2026) Table 44. Global Oncolytic Virus Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Oncolytic Virus Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Oncolytic Virus Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Oncolytic Virus Sales by Country (2021-2026) & (K Units) Table 48. North America Oncolytic Virus Sales by Country (2027-2032) & (K Units) Table 49. Europe Oncolytic Virus Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Oncolytic Virus Sales by Country (2021-2026) & (K Units) Table 51. Europe Oncolytic Virus Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Oncolytic Virus Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Oncolytic Virus Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Oncolytic Virus Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Oncolytic Virus Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Oncolytic Virus Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Oncolytic Virus Sales by Country (2027-2032) & (K Units) Table 58. Global Oncolytic Virus Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Oncolytic Virus Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Oncolytic Virus Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Oncolytic Virus Revenue Market Share by Region (2021-2026) Table 62. Global Oncolytic Virus Revenue Market Share by Region (2027-2032) Table 63. Amgen Company Information Table 64. Amgen Business Overview Table 65. Amgen Oncolytic Virus Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Amgen Oncolytic Virus Product Portfolio Table 67. Amgen Recent Development Table 68. Shanghai Sunway Biotech Company Information Table 69. Shanghai Sunway Biotech Business Overview Table 70. Shanghai Sunway Biotech Oncolytic Virus Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Shanghai Sunway Biotech Oncolytic Virus Product Portfolio Table 72. Shanghai Sunway Biotech Recent Development Table 73. Key Raw Materials Table 74. Raw Materials Key Suppliers Table 75. Oncolytic Virus Distributors List Table 76. Oncolytic Virus Customers List Table 77. Research Programs/Design for This Report Table 78. Authors List of This Report Table 79. Secondary Sources Table 80. Primary Sources List of Figures Figure 1. Oncolytic Virus Product Image Figure 2. Global Oncolytic Virus Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oncolytic Virus Market Size (2021-2032) & (US$ Million) Figure 4. Global Oncolytic Virus Sales (2021-2032) & (K Units) Figure 5. Global Oncolytic Virus Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Oncolytic Virus Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Imlygic Image Figure 9. Oncorine Image Figure 10. Others Image Figure 11. Global Oncolytic Virus Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Oncolytic Virus Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Oncolytic Virus Sales Market Share by Type (2021-2032) Figure 14. Global Oncolytic Virus Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Oncolytic Virus Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Oncolytic Virus Revenue Market Share by Type (2021-2032) Figure 17. Melanoma Image Figure 18. Other Cancers Image Figure 19. Global Oncolytic Virus Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Oncolytic Virus Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Oncolytic Virus Sales Market Share by Application (2021-2032) Figure 22. Global Oncolytic Virus Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Oncolytic Virus Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Oncolytic Virus Revenue Market Share by Application (2021-2032) Figure 25. North America Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Oncolytic Virus Sales Market Share by Country (2021-2032) Figure 27. U.S. Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Oncolytic Virus Sales Market Share by Country (2021-2032) Figure 32. Germany Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Oncolytic Virus Sales Market Share by Country (2021-2032) Figure 39. China Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Oncolytic Virus Sales Market Share by Country (2021-2032) Figure 47. Brazil Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Oncolytic Virus Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Oncolytic Virus Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Oncolytic Virus Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Oncolytic Virus Revenue (2021-2032) & (US$ Million) Figure 58. North America Oncolytic Virus Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Oncolytic Virus Revenue (2021-2032) & (US$ Million) Figure 60. Europe Oncolytic Virus Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Oncolytic Virus Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Oncolytic Virus Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Oncolytic Virus Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Oncolytic Virus Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Oncolytic Virus Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Oncolytic Virus Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Imlygic
  • Oncorine
  • Others
Applications
  • Melanoma
  • Other Cancers
Companies covered
  • Amgen
  • Shanghai Sunway Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oncolytic Virus Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oncolytic Virus Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oncolytic Virus Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oncolytic Virus Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oncolytic Virus Market Dynamics
  1. 2.1 Oncolytic Virus Industry Trends
  2. 2.2 Oncolytic Virus Industry Drivers
  3. 2.3 Oncolytic Virus Industry Opportunities and Challenges
  4. 2.4 Oncolytic Virus Industry Restraints
3 Oncolytic Virus Market by Manufacturers
  1. 3.1 Global Oncolytic Virus Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oncolytic Virus Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oncolytic Virus Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oncolytic Virus Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oncolytic Virus Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oncolytic Virus Manufacturers, Product Type & Application
  7. 3.7 Global Oncolytic Virus Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oncolytic Virus Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oncolytic Virus Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oncolytic Virus Tier 1, Tier 2, and Tier 3
4 Oncolytic Virus Market by Type
  1. 4.1 Oncolytic Virus Type Introduction
  2. 4.1.1 Imlygic
  3. 4.1.2 Oncorine
  4. 4.1.3 Others
  5. 4.2 Global Oncolytic Virus Sales by Type
  6. 4.2.1 Global Oncolytic Virus Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Oncolytic Virus Sales by Type (2021-2032)
  8. 4.2.3 Global Oncolytic Virus Sales Market Share by Type (2021-2032)
  9. 4.3 Global Oncolytic Virus Revenue by Type
  10. 4.3.1 Global Oncolytic Virus Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Oncolytic Virus Revenue by Type (2021-2032)
  12. 4.3.3 Global Oncolytic Virus Revenue Market Share by Type (2021-2032)
5 Oncolytic Virus Market by Application
  1. 5.1 Oncolytic Virus Application Introduction
  2. 5.1.1 Melanoma
  3. 5.1.2 Other Cancers
  4. 5.2 Global Oncolytic Virus Sales by Application
  5. 5.2.1 Global Oncolytic Virus Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Oncolytic Virus Sales by Application (2021-2032)
  7. 5.2.3 Global Oncolytic Virus Sales Market Share by Application (2021-2032)
  8. 5.3 Global Oncolytic Virus Revenue by Application
  9. 5.3.1 Global Oncolytic Virus Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Oncolytic Virus Revenue by Application (2021-2032)
  11. 5.3.3 Global Oncolytic Virus Revenue Market Share by Application (2021-2032)
6 Global Oncolytic Virus Sales by Region
  1. 6.1 Global Oncolytic Virus Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oncolytic Virus Sales by Region (2021-2032)
  3. 6.2.1 Global Oncolytic Virus Sales by Region (2021-2026)
  4. 6.2.2 Global Oncolytic Virus Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oncolytic Virus Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oncolytic Virus Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oncolytic Virus Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oncolytic Virus Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oncolytic Virus Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oncolytic Virus Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oncolytic Virus Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oncolytic Virus Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oncolytic Virus Revenue by Region
  1. 7.1 Global Oncolytic Virus Revenue by Region
  2. 7.1.1 Global Oncolytic Virus Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oncolytic Virus Revenue by Region (2021-2026)
  4. 7.1.3 Global Oncolytic Virus Revenue by Region (2027-2032)
  5. 7.1.4 Global Oncolytic Virus Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oncolytic Virus Revenue (2021-2032)
  8. 7.2.2 North America Oncolytic Virus Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oncolytic Virus Revenue (2021-2032)
  11. 7.3.2 Europe Oncolytic Virus Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oncolytic Virus Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oncolytic Virus Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oncolytic Virus Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oncolytic Virus Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Amgen
  2. 8.1.1 Amgen Company Information
  3. 8.1.2 Amgen Business Overview
  4. 8.1.3 Amgen Oncolytic Virus Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Amgen Oncolytic Virus Product Portfolio
  6. 8.1.5 Amgen Recent Developments
  7. 8.2 Shanghai Sunway Biotech
  8. 8.2.1 Shanghai Sunway Biotech Company Information
  9. 8.2.2 Shanghai Sunway Biotech Business Overview
  10. 8.2.3 Shanghai Sunway Biotech Oncolytic Virus Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Sunway Biotech Oncolytic Virus Product Portfolio
  12. 8.2.5 Shanghai Sunway Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oncolytic Virus Value Chain Analysis
  2. 9.1.1 Oncolytic Virus Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oncolytic Virus Production Mode & Process
  6. 9.2 Oncolytic Virus Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oncolytic Virus Distributors
  9. 9.2.3 Oncolytic Virus Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst